LMP-associated proteolytic activities and TAP-dependent peptide transport for class I MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12

Journal of Experimental Medicine

Volumn 183, Issue 2, 1996, Pages 499-514

  Rotem Yehudar, Rinat ^a   Groettrup, Marcus ^b   Soza, Andrea ^b   Kloetzel, Peter M ^b   Ehrlich, Rachel ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME;

ADENOVIRUS 12; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL TRANSFORMATION; CELL TRANSPORT; EMBRYO; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; VIRUS TRANSFORMATION;

ANIMALS; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELL LINE; CELL TRANSFORMATION, VIRAL; CYSTEINE ENDOPEPTIDASES; ENDOPEPTIDASES; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; MASTADENOVIRUS; MICE; MICE, TRANSGENIC; MULTIENZYME COMPLEXES; ONCOGENIC VIRUSES; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; SWINE;

EID: 0030027127     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.2.499     Document Type: Article

References (74)

1. Zinkernagel, R., and P.C. Doherty. 1979. MHC restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction, function and responsiveness. Adv. Immunol 22:51-177.
2. Goodenow, R.S., J.M. Vogel, and R.L. Linsk. 1985. Histocompatibility antigens on murine tumors. Science (Wash. DC). 230:777-783.
3. Hämmerling, G.J., D. Klar, W. Pulm, F. Momburg, and G. Moldenhauer. 1987. The influence of MHC class I antigens on tumor growth and metastasis. Biochim. Biophys. Acta. 179: 245-259.
4. Elliot, B.E., D.A. Carlow, A. Rodricks, and A. Wade. 1989. Perspectives on the role of MHC antigens in normal and malignant cell development. Adv. Cancer Res. 53:181-245.
5. Tanaka, K., A. Isselbacher, G. Khoury, and G. Jay. 1985. Reversal of oncogenesis by the expression of a major histocompanbility complex class I gene. Science (Wash. DC). 228:26-30.
6. Weis, J-H., and J.G. Seidman. 1985. The expression of major histocompatibility antigen under metallothionein gene promoter control. J. Immunol. 134:1999-2003.
7. Yewdell, J.W., and J.R. Bennik. 1992. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv. Immunol. 52:1-123.
8. Germain, R.N., and D.H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403-450.
9. Kast, W.M., R. Offringa, P.J. Peters, A.C. Voordouw, R.H. Meloen, A.J. Van der Eb, and C.J.M. Melief. 1989. Eradication of adenovirus-E1-induced tumor by E1a specific cytotoxic T lymphocytes. Cell. 59:603-614.
10. Van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Kruth, and T. Boon. 1991. A gene encoding an antigen recognized by cytotoxic T lymphocytes on a human melanoma. Science (Wash. DC). 254:1643-1647.
11. Schreiber, H., P.L. Ward, D.A. Rowly, and H.J. Strauss. 1988. Unique tumor specific antigens. Annu. Rev. Immunol. 6:465-483.
12. Monaco, J.J. 1982. A molecular model for class I-restricted antigen processing. Immunol. Today. 13:173-179.
13. Jackson, M.R., and P.A. Peterson. 1993. Assembly and intra-cellular transport of MHC class I molecules. Annu. Rev. Cell. Biol. 9:207-235.
14. + T cells. Cell. 71:1205-1214.
15. Spies, T., and R. DeMars. 1991. Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature (Lond.). 351:323-324.
16. Attaya, M., S. Jameson, C.K. Martinez, E. Hermel, C. Aldrich, J. Forman, K. Fischer Lindahl, M.J. Bevan, and J.J. Monaco. 1992. Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature (Lond.). 355:647-649.
17. Goldberg, A.L., and K.L. Rock. 1992. Proteolysis, proteasomes and antigen presentation. Nature (Lond.). 357:375-379.
18. Rock, L.R., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A.L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 78:761-771.
19. Townsend, A., J. Bastin, K. Gould, G. Brownlee, M. Andrew, B. Coupar, D. Boyle, S. Chan, and G. Smith. 1988. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J. Exp. Med. 168:1211-1224.
20. Kelly, A., S.H. Powis, R. Glynne, E. Radley, S. Beck, and J. Trowsdale 1991. Second proteasome-related gene in the human MHC class II region. Nature (Lond.). 353:667-668.
21. Martinez, C.K., and J.J. Monaco. 1991. Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene. Nature (Lond.). 353:664-667.
22. Glynnc, R., S.H. Powis, S. Beck, A. Kelly, L.-A. Kerr, and J. Trowsdale. 1991. A proteasome-related gene between the two ABC transporter Ioci in the class II region of the human MHC. Nature (Lond.). 353:357-360.
23. Yang, Y., J.B. Waters, K. Früh, and P.A. Peterson. 1992. Proteasomes are regulated by interferon-γ: implications for antigen processing. Proc. Natl. Acad. Sci. USA. 89:4928-4932.
24. Driscoll, J., M.G. Brown, D. Finely, and J.J. Monaco. 1993. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature (Lond.). 365:262-264.
25. Gaczynska, M., K.L. Rock, and A.L. Goldberg. 1993. γ-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature (Lond.). 365:264-267.
26. Aki, M., N. Shimbara, M. Takashina, K. Akiyarna, S. Kagawa, T. Tamura, N. Tanahashi, T. Tanaka, and A. Ichirhara. 1994. Interferon-γ induces different subunit organizations and functional diversity of proteasomes. J. Biochem. 115:257-269.
27. Boes, B., H. Hengel, T. Ruppert, G. Mulchaup, U.H. Koszinowski, and P.-M. Kloetzel. 1994. Interferon γ stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes. J. Exp. Med. 179:901-909.
28. Fehling, H.J., W. Swat, C. Laplace, R. Kühn, K. Rajewsky, U. Muller, and H. von Boehmer. 1994. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science (Wash. DC). 265:1234-1237.
29. Cerundolo, V., A. Kelly, T. Elliot, J. Trowsdale, and A. Townsend. 1995 Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport. Eur. J. Immunol. 25:554-562.
30. Restifo, N.P., F. Esquivel, Y. Kawakami, J.W. Yewdell, J.J. Mule, S.A. Rosenberg, and J. Bennink. 1993. Identification of human cancers deficient in antigen processing. J. Exp. Med. 177:265-272.
31. Rotem-Yehudar, R., S. Winograd, S. Sela, J.E. Coligan, and R. Ehrlich. 1994. Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12. J. Exp. Med. 180:477-488.
32. Cromme, F.V., J. Airey, M -T. Heemels, H.L Ploegh, P.J. Keating, P.L. Stern, C.J.L.M. Meijer, and J.M.M. Walboomers. 1994. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J. Exp. Med. 179:335-340.
33. Khanna, R., S.R. Burrows, V. Argaet, and D. Moss. 1994. Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes, restores immunogenicity of an antigen processing defective tumor cell line. Int. Immunol. 6:639-645.
34. Cromme, F.V., C.J.L.M. Meijer, P.J.F. Smjders, U. Uyterlinde, P. Kenemans, T. Helmerhorst, P.L. Stem, A.J.C. van der Brule, and J.M.M. Walboomers. 1993. Analysis of MHC class I and class II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions. Br. J. Cancer 67:1372-1380.
35. Gavioli, R., P.-O. De Campos-Lima, M.G. Kurilla, E. Kieff, G. Klein, and M.G. Masucci. 1992. Recognition of the EBV encoded nuclear antigens EBNA-4 and EBNA-6 by HLA A11 restricted cytotoxic T-lymphocytes. Implications for the down regulation of HLA A11 in Burkitt's lymphoma. Proc. Natl. Acad. Sci. USA. 89:5862-5866.
36. Cromme, F.V., P.F.J. van Bommel, J.M.M. Walboomers. M.P W. Gallee, P.L. Stern, P. Kenemans, T.J.M. Helmerhorst, M.J. Stukart, and C.J.L.M. Meijer. 1994. Differences in MHC and TAP1 expression in cervical cancer lymph metastases as compared with primary tumors. Br. J. Cancer. 69: 1176-1181.
37. Graham, F.L. 1984. Transformation by and oncogenicity of human adenoviruses. In The Adenoviruses, H. Ginsberg, editor, Plenum Publishing Corp., New York. 339-398.
38. Shemesh, J., R. Rotem-Yehudar, and R. Ehrlich. 1991. Transcriptional and posttranscriptional regulation of class I major histocompatibility complex genes following infection and transformation with human adenoviruses. J. Virol. 65:5544-5548.
39. Bashi, O., and R. Ehrlich. 1995. Characterization of mature and immature RadLV-induced thymic T-cell lines for tumorigenesis and MHC-class I gene expression. Int. J. Cancer. 61:67-75.
40. Jacoby, W.B., and I.H. Pastan 1979. Cell culture. Methods Enzymol. 58:110-116.
41. Yewdell, J.W., E. Fernando, D. Arnold, T. Spies, L.C. Eisenlohr, and J.R. Bennink. 1993. Presentation of numerous viral peptides to mouse major histocompatibility complex (MHC) class I-restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse-human transporter. J. Exp. Med. 177:1785-1790.
42. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature (Lond.). 375: 411-415.
43. Yuwen, H., J.H. Cox, J.W. Yewdell, J.R. Bennink, and B. Moss. 1993. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. Virology 195:732-744.
44. Cleveland, D.W., M.A. Lopata, R.J. MacDonald, N.J. Cowan, W.J. Rutter, and M.W. Kirschner. 1980. Number and evolutionary conservation of α and β tubulin and cytoplasmic β and γ actin genes using specific cloned cDNA probes. Cell. 20: 95-105.
45. Monaco, J.J., S. Cho, and M. Attaya. 1990. Transport protein genes in the murine MHC: possible implications for antigen processing. Science (Wash. DC). 250:1723-1726.
46. b haplotype reveal genetic control of isotype expression. J. Immunol. 126:317-321.
47. Allen, H., J.D. Wraith, P. Pala, B. Askonas, and R.A. Flavell. 1984. Domain intersections of H-2 class I antigens after cytotoxic T-cell recognition sites. Nature (Lond.). 309:279-281.
48. 2microglobulin in the intracellular transport and cell surface expression of murine class I histocompatibility molecules. J. Immunol. 142:2796-2806.
49. 2-microglobulin folding, and peptides on class I MHC folding and assembly in an in vitro translation system. J. Immunol. 149:2935-2944
50. Davis, W.C., S. Marusic, H.A. Lewin, G.A. Splitter, L.E. Perryman, T.C. McGuire, and J.R. Gorham. 1987. The development and analysis of species specific and cross reactive monoclonal antibodies to leukocyte differentiation antigens and antigens of the major histocompatibility complex for use in the study of the immune system in cattle and other species. Vet Immunol. Immunopathol. 15:337-376.
51. Frentzel, S., I. Kahn-Hartman, M. Gernold, P. Gött, A. Seelig, and P.-M. Kloetzel. 1993. The major histocompatibility complex encoded β-chain type proteasome subunits LMP2 and LMP7. Evidence that LMP2 and LMP7 are synthesized as proproteins and that cellular levels of both mRNA and LMP-containing proteasomes are differentially regulated. Eur. J. Biochem. 216:119-126.
52. Seelig, A., B. Boes, and P.-M. Kloetzel. 1993. Characterization ot mouse proteasome subunit MC3 and identification of proteasome subtypes with different cleavage characteristics. Enzyme & Protein. 47:330-342.
53. White, B.A., and F.C. Bancroft. 1982. Cytoplasmic dot hybridization. Simple analysis of relative mRNA levels in multiple small cell or tissue samples. J. Biol. Chem. 257:8569-8572.
54. Frentzel, S., B. Pesold-Hurt, A. Seelig, and P.-M. Kloetzel. 1994. 20S proteasomes are assembled via distinct precursor complexes. Processing of LMP2 and LMP7 proproteins takes place in 13-16S proteasome complexes. J. Mol. Biol. 236: 975-981.
55. Shemesh, J., and R. Ehrlich. 1993. Aberrant biosynthesis and transport of class I major histocompatibility complex molecules in cells transformed with highly oncogenic human adenoviruses. J. Biol. Chem. 268:15704-15711.
56. Otten, G.R., E. Bikoff, R.K. Ribaudo, S. Kozlowski, D.H. Margulies, and R.N. Germain. 1992. Peptide and β2microglobulin regulation of cell surface MHC class I conformation and expression. J. Immunol. 148:3723-3732.
57. Sugita, M., and M.B. Brenner. 1994. An unstable β2microglobulin: major histocompatibility complex class I heavy chain intermediate dissociates from calnexin and then is stabilized by binding peptides J. Exp. Med. 180:2163-2171.
58. Gaczynska, M., K.L. Rock, T. Spies, and A.L. Goldberg. 1994. Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Proc. Natl. Acad. Sci. USA. 20: 9213-9217.
59. Schrier, P.I., R. Bernards, R.T.M.J. Vaessen, A. Houweling, and A.J. Van der Eb. 1983. Expression of class I MHC switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature (Lond.). 305:771-775.
60. Eager, K., J. Williams, D. Breiding, S. Pans, B. Knowles, E. Appella, and R.P. Riccardi. 1985. Expression of histocompatibility antigens H-2K, -D, and L is reduced in adenovirus 12 transformed mouse cells and is restored by IFN. Proc. Natl. Acad Sci. USA. 82:5525-5529.
61. Braithwaite, A.W., C.C. Nelson, and J.D. Bellet. 1991. E1a revisited: the case for multiple cooperative trans-activation domains. The New Biologist. 3:18-26.
62. Williams, D.B., S.J. Swiedler, and G.W. Hart. 1985. Intracellular transport of membrane glycoproteins: two closely related histocompatibility antigens differ in their rate of transit to the cell surface. J. Biol. Chem. 263:4549-4560.
63. Jefferies, W.A., and H.-G. Burgert. 1990. E3/19K from adenovirus 2 is an immunosubversive protein that binds to a structural motif regulating the intracellular transport of major histocompatibility complex class I proteins. J. Exp. Med. 172: 1653-1664.
64. Hill, A., M. Takiguchi, and A. McMichael. 1993. Different rates of HLA class I molecule assembly, which are determined by amino acid sequence in the α2 domain. Immunogenetics. 37:95-101.
65. Neefjes, J.J., and H.L. Ploegh. 1988. Allelic and locus specific differences in cell-surface expression and the association of HLA class I heavy chain with β2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association. Eur. J. Immunol. 18:801-810.
66. Hill, A B., B.C. Barnett, A.J. McMichael, and D.J. McGeoch. 1994. HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus type 1 and 2. J. Immunol. 152:2736-2741.
67. Kahn-Perlès, B., J. Salamero, and O. Jouans. 1994. Biogenesis of MHC class I antigens: involvement of multiple chaper-one molecules. Eur. J. Cell Biol. 64:176-185.
68. Nössner, E., and P. Parham. 1995. Species-specific differences in chaperone interaction of human and mouse histocompatibility complex class I molecules. J. Exp. Med. 181: 327-337.
69. Anderson, S.L., T. Shen, J. Lou, L. Xing, N.E. Blachere, P.K. Srivastava, and B.Y. Rubin. 1994. The endoplasmic reticular heat shock protein gp96 is transcriptionally upregulated in interferon-treated cells. J. Exp. Med. 180:1565-1569.
70. Van Kaer, L., P.G. Ashton-Rickardt, M. Eichelberger, M. Gaczynska, K. Nagashima, K.L. Rock, A.L. Goldberg, P. Doherty, and S. Tonegawa. 1994. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity. 1:533-541.
71. Arnold, D., J. Dnscoll, M. Androlewicz, E. Hughes, P. Creswell, and T. Spies. 1992. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules. Nature (Lond.). 360: 171-174.
72. Momburg, F., V. Ortiz-Navarrete, J. Neefjes, E. Goulmv, Y. van de Val, and G. Hämmerling. 1992. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation. Nature (Lond.). 360:174-177.
73. Yewdell, J.W., J.C. Laphham, I. Bacik, T. Spies, and J. Bennink. 1994. MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation. J. Immunol. 152:1163-1170.
74. Brown, M.G., J. Driscoll, and J.J. Monaco. 1993. MHC-linked low-molecular mass polypeptide subunits define distinct subsets of proteasomes. Implications for divergent function among distinct proteasome subsets. J. Immunol. 151: 1193-1204.